BioSpectrum Asia - June 2017Add to Favorites

Get BioSpectrum Asia along with 5,000+ other magazines & newspapers

Try FREE for 7 days

bookLatest and past issues of 5,000+ magazines & newspapersphoneDigital Access. Cancel Anytime.

1 Year$99.99 $49.99 Save 50%

bookLatest and past issues of 5,000+ magazines & newspapersphoneDigital Access. Cancel Anytime.
(Or)

Get BioSpectrum Asia

1 Year $10.99

Save 7%
book12 issues starting from BioSpectrum Asia July 2021 phoneDigital Access. Cancel Anytime.

Buy this issue $0.99

bookJune 2017 issue phoneDigital Access.

Gift BioSpectrum Asia

  • Magazine Details
  • In this issue

Magazine Description

In this issue

ASIA: Preferred destination for clinical trials Globally clinical trials are expected to grow at a compound annual growth rate (CAGR) of 12.4 percent to reach USD57 billion in revenue in 2020 from USD31.8 billion in 2015. During 2015-2020, while the CRO market in North America is expected to grow at 10.4 percent CAGR, the Asia Pacific CRO market is forecasted to grow at a CAGR of 19.9 percent. The key drivers for this growth are increased R&D activity and shift toward outsourcing. More than three-quarters of R&D spending by biotechnology and pharmaceutical companies can be potentially outsourced. There is a significant increase in the CRO market, through increased outsourcing alone with penetration expected to increase from 29 percent in 2015 to 43 percent in 2020. Asian growth is expected to be even higher as clinical trial penetration in Asia in 2015 was even lower than the global penetration, at around 15 percent.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
RECENT STORIES FROM BIOSPECTRUM ASIAView All